Xenotransplantation of porcine islet cells as a potential option for the treatment of type 1 diabetes in the future

Hormone and Metabolic Research

Volumn 47, Issue 1, 2015, Pages 31-35

  Reichart, B ^a   Niemann, H ^b   Chavakis, T ^c,d,e   Denner, J ^f   Jaeckel, E ^g   Ludwig, B ^c,d,h   Marckmann, G ⁱ   Schnieke, A ^j   Schwinzer, R ^g   Seissler, J ⁱ   Tonjes R R ^k   Klymiuk, N ⁱ   Wolf, E ⁱ   Bornstein, S R ^c,d,h,l  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f ROBERT KOCH INSTITUTE   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k PAUL EHRLICH INSTITUT   (Germany)

^l KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

diabetes mellitus type 1; islet cells; xenotransplantation

Indexed keywords

GLYCEMIC CONTROL; GRAFT REJECTION; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SWINE; TREATMENT OUTCOME; TREATMENT RESPONSE; XENOTRANSPLANTATION; ANIMAL; CYTOLOGY; DIABETES MELLITUS, TYPE 1; IMMOBILIZED CELL; IMMUNOLOGY; METABOLISM; PANCREAS ISLET; PIG; XENOGRAFT;

PRIMATES; SUS;

ANIMALS; CELLS, IMMOBILIZED; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; SUS SCROFA; TRANSPLANTATION, HETEROLOGOUS;

EID: 84920747031     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1395518     Document Type: Review

References (63)

1. Ludwig B., Barthel A., Reichel A., Block N. L., Ludwig S., Schally A. V., Bornstein S. R. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus. Vitam Horm: 2014; 95 195 222
2. Achenbach P., Bonifacio E., Koczwara K., Ziegler A. G. Natural history of type 1 diabetes. Diabetes: 2005; 54 02 S25 S31
3. Meier J. J. Beta cell mass in diabetes: A realistic therapeutic target? Diabetologia: 2008; 51 703 713
4. Ludwig B., Reichel A., Kruppa A., Ludwig S., Steffen A., Weitz J., Bornstein S. R. Islet transplantation at the Dresden Diabetes Center: five years' experience. Horm Metab Res: 2015; 47 4 8
5. Collaborative Islet Transplant Registry (CITR) www.citregistry.org
6. Zimmerhackl L. B., Jungraithmayr T. C., Tibell A. Marginal donors in pediatric solid organ transplantation. Pediatric transplantation: 2010; 14 154 155
7. Morris M. I., Fischer S. A., Ison M. G. Infections transmitted by transplantation. Infect Dis Clin North Am: 2010; 24 497 514
8. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell: 2006; 126 663 676
9. Laflamme M. A., Murry C. E. Heart regeneration. Nature: 2011; 473 326 335
10. Weissman I. L., Shizuru J. A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood: 2008; 112 3543 3553
11. Huang P., He Z., Ji S., Sun H., Xiang D., Liu C., Hu Y., Wang X., Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature: 2011; 475 386 389
12. Vierbuchen T., Ostermeier A., Pang Z. P., Kokubu Y., Sudhof T. C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature: 2010; 463 1035 1041
13. van der Windt D. J., Bottino R., Casu A., Campanile N., Smetanka C., He J., Murase N., Hara H., Ball S., Loveland B. E., Ayares D., Lakkis F. G., Cooper DK C., Trucco M. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant: 2009; 9 2716 2726
14. Dufrane D., Goebbels R. M., Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation: 2010; 90 1054 1062
15. Cardona K., Korbutt G. S., Milas Z., Lyon J., Cano J., Jiang W., Bello-Laborn H., Hacquoil B., Strobert E., Gangappa S., Weber C. J., Pearson T. C., Rajotte R. V., Larsen C. P. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med: 2006; 12 304 306
16. Hering B. J., Wijkstrom M., Graham M. L., Hardstedt M., Aasheim T. C., Jie T., Ansite J. D., Nakano M., Cheng J., Li W., Moran K., Christians U., Finnegan C., Mils C. D., Sutherland D. E., Bansal-Pakala P., Murtaugh M. P., Kirchof N., Schurman H-J. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med: 2006; 12 301 303
17. Elliott R. B. Towards xenotransplantation of pig islets in the clinic. Curr Opin Organ Transplant: 2011; 16 195 200
18. Elliott R. B., Escobar L., Garkavenko O., Croxson M. C., Schroeder B. A., McGregor M., Ferguson G., Beckman N., Ferguson S. No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant: 2000; 9 895 901
19. Garkavenko O., Croxson M. C., Irgang M., Karlas A., Denner J., Elliott R. B. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol: 2004; 42 5353 5356
20. Valdés-González R. A., Dorantes L. M., Garibay G. N., Bracho-Blanchet E., Mendez A. J., Dávila-Pérez R., Elliott R. B., Terán L., White D. J. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol: 2005; 153 419 427
21. Tuch B. E., Keogh G. W., Williams L. J., Wu W., Foster J. L., Vaithilingam V., Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care: 2009; 32 1887 1889
22. Basta G., Montanucci P., Luca G., Boselli C., Noya G., Barbaro B., Qi M., Kinzer K. P., Oberholzer J., Calafiore R. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care: 2011; 34 2406 2409
23. Wynyard S., Nathu D., Garkavenko O., Denner J., Elliott R. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation: 2014; 21 309 323
24. Elliott R. B., Escobar L., Tan P. L., Muzina M., Zwain S., Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5'yr after xenotransplantation. Xenotransplantation: 2007; 14 157 161
25. Ekser B., Ezzelarab M., Hara H., van der Windt D. J., Wijkstrom M., Bottino R., Trucco M., Cooper D. K. Clinical xenotransplantation: the next medical revolution? Lancet: 2012; 379 672 683
26. Cooper D. K., Satyananda V., Ekser B., van der Windt D. J., Hara H., Ezzelarab M. B., Schuurman H. J. Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature. Xenotransplantation: 2014; 21 397 419
27. Nagaraju S., Bottino R., Wijkstrom M., Trucco M., Cooper D. K. Islet xenotransplantation: what is the optimal age of the islet-source pig? Xenotransplantation: 2014; Aug 11 10.1111/xen.12130 [Epub ahead of print]
28. Mohiuddin M. M., Singh A. K., Corcoran P. C., Hoyt R. F., Thomas M. L. 3rd, Lewis B. G., Eckhaus M., Reimann K. A., Klymiuk N., Wolf E., Ayares D., Horvath K. A. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am J Transplant: 2014; 14 488 489
29. Cozzi E., Tallacchini M., Flanagan E. B., Pierson R. N. 3rd, Sykes M., Vanderpool H. Y. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework. Xenotransplantation: 2009; 16 203 214
30. Katholische Akademie Bayern www.kath-akademie-bayern.de Zur Debatte, Heft 63/2014
31. Mueller N. J., Takeuchi Y., Mattiuzzo G., Scobie L. Microbial safety in xenotransplantation. Curr Opin Organ Transplant: 2011; 16 201 206
32. Scobie L., Takeuchi Y. Porcine endogenous retrovirus and other viruses in xenotransplantation. Curr Opin Organ Transplant: 2009; 14 175 179
33. Semaan M., Rotem A., Barkai U., Bornstein S., Denner J. Screening pigs for xenotransplantation: prevalence and expression of porcine endogenous retroviruses in Göttingen minipigs. Xenotransplantation: 2013; 20 148 156
34. Denner J., Tönjes R. R. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev: 2012; 25 318 343
35. Denner J., Schuurman H. J., Patience C. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation: 2009; 16 239 248
36. Denner J., Tönjes R., Takeuchi Y., Fishman J., Linda Scobie L. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 5: Recipient monitoring and response plan for preventing disease transmission. Xenotransplantation in preparation
37. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., O'Malley P., Nobori S., Vagefi P. A., Patience C., Fishman J., Cooper D. K., Hawley R. J., Greenstein J., Schuurman H. J., Awwad M., Sykes M., Sachs D. H. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med: 2005; 11 32 34
38. Kuwaki K., Tseng Y. L., Dor F. J., Shimizu A., Houser S. L., Sanderson T. M., Lancos C. J., Prabharasuth D. D., Cheng J., Moran K., Hisashi Y., Mueller N., Yamada K., Greenstein J. L., Hawley R. J., Patience C., Awwad M., Fishman J. A., Robson S. C., Schuurman H. J., Sachs D. H., Cooper D. K. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med: 2005; 11 29 31
39. Ekser B., Kumar G., Veroux M., Cooper D. K. Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates. Curr Opin Organ Transplant: 2011; 16 222 230
40. Mohiuddin M. M., Singh A. K., Corcoran P. C., Hoyt R. F., Thomas M. L. 3rd, Ayares D., Horvath K. A. Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J Thorac Cardiovasc Surg: 2014; 148 1106 1113
41. Petersen B., Ramackers W., Lucas-Hahn A., Lemme E., Hassel P., Queisser A. L., Herrmann D., Barg-Kues B., Carnwath J. W., Klose J., Tiede A., Friedrich L., Baars W., Schwinzer R., Winkler M., Niemann H. Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation: 2011; 18 355 368
42. Oropeza M., Petersen B., Carnwath J. W., Lucas-Hahn A., Lemme E., Hassel P., Herrmann D., Barg-Kues B., Holler S., Queisser A. L., Schwinzer R., Hinkel R., Kupatt C., Niemann H. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation: 2009; 16 522 534
43. Petersen B., Ramackers W., Tiede A., Lucas-Hahn A., Herrmann D., Barg-Kues B., Schuettler W., Friedrich L., Schwinzer R., Winkler M., Niemann H. Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation: 2009; 16 486 495
44. Ezzelarab M., Garcia B., Azimzadeh A., Sun H., Lin C. C., Hara H., Kelishadi S., Zhang T., Lin Y. J., Tai H. C., Long C., Wagner R., Thacker J., Murase N., McCurry K., Barth R. N., Ayares D., Pierson R. N. 3rd, Cooper DK C. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation: 2009; 87 805 812
45. Poirier N., Azimzadeh A. M., Zhang T., Dilek N., Mary C., Nguyen B., Tillou X., Wu G., Reneaudin K., Hervouet J., Martinet B., Coulon F., Allain-Launay E., Karam G., Soulillou J. P., Pierson R. N. 3rd, Blancho G., Vanhove B. Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation. Sci Translat Med: 2010; 2 17ra10
46. Klymiuk N., van Buerck L., Bähr A., Offers M., Kessler B., Wuensch A., Kurome M., Thormann M., Lochner K., Nagashima H., Herbach N., Wanke R., Seissler J., Wolf E. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes: 2012; 61 1527 1532
47. Del Rio M. L., Seebach J. D., Fernandez-Renedo C., Rodriguez-Barbosa J. I. ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responses. Xenotransplantation: 2013; 20 397 406
48. Ding Q., Lu L., Zhou X., Zhou Y., Chou K. Y. Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells. J Leukoc Biol: 2011; 90 77 86
49. Plege-Fleck A., Lieke T., Römermann D., Düvel H., Hundrieser J., Buermann A., Kraus L., Klempnauer J., Schwinzer R. Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1. Xenotransplantation: 2014; Jul 9 10.1111/xen.12121 [Epub ahead of print]
50. Waldmann H., Adams E., Fairchild P., Cobbold S. Regulation and privilege in transplantation tolerance. J Clin Immunol: 2008; 28 716 725
51. Muller Y. D., Golshayan D., Ehirchiou D., Wekerle T., Seebach J. D., Buhler L. H. T regulatory cells in xenotransplantation. Xenotransplantation: 2009; 16 121 128
52. Inverardi L., Pardi R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev: 1994; 141 71 93
53. Schneider M. K., Seebach J. D. Current cellular innate immune hurdles in pig-to-primate xenotransplantation. Curr Opin Organ Transplant: 2008; 13 171 177
54. Li S., Waer M., Billiau A. D. Xenotransplantation: role of natural immunity. Transplant Immunol: 2009; 21 70 74
55. Weiss E. H., Lilienfeld B. G., Muller S., Muller E., Herbach N., Kessler B., Wanke R., Schwinzer R., Seebach J. D., Wolf E., Brem G. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation: 2009; 87 35 43
56. Marigliano M., Bertera S., Grupillo M., Trucco M., Bottino R. Pig-to-nonhuman primates pancreatic islet xenotransplantation: an overview. Curr Diab Rep: 2011; 11 402 412
57. Goto M., Tjernberg J., Dufrane D., Elgue G., Brandhorst D., Ekdahl K. N., Brandhorst H., Wennberg L., Kurokawa Y., Satomi S., Lambris J. D., Gianello P., Korsgren O., Nilsson B. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation: 2008; 15 225 234
58. Vaithilingam V., Tuch B. E. Islet transplantation and encapsulation: an update on recent developments. Rev Diabetic Studies: 2011; 8 51 67
59. Ludwig B., Zimerman B., Steffen A., Yavriants K., Azarov D., Reichel A., Vardi P., German T., Shabtay N., Rotem A., Evron Y., Neufeld T., Mimon S., Ludwig S., Brendel M. D., Bornstein S. R., Barkai U. A novel device for islet transplantation providing immune protection and oxygen supply. Horm Metab Res: 2010; 42 918 922
60. Ludwig B., Rotem A., Schmid J., Weir G. C., Colton C. K., Brendel M. D., Neufeld T., Block N. L., Yavriyants K., Steffen A., Ludwig S., Chavakis T., Reichel A., Azarov D., Zimermann B., Maimon S., Balyura M., Rozenshtein T., Shabtay N., Vardi P., Bloch K., de Vos P., Schally A. V., Bornstein S. R., Barkai U. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci USA: 2012; 109 5022 5027
61. Barkai U., Weir G. C., Colton C. K., Ludwig B., Bornstein S. R., Brendel M. D., Neufeld T., Bremer C., Leon A., Evron Y., Yavriyants K., Azarov D., Zimermann B., Maimon S., Shabtay N., Balyura M., Rozenshtein T., Vardi P., Bloch K., de Vos P., Rotem A. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant: 2013; 22 1463 1476
62. Neufeld T., Ludwig B., Barkai U., Weir G. C., Colton C. K., Evron Y., Balyura M., Yavriyants K., Zimermann B., Azarov D., Maimon S., Shabtay N., Rozenshtein T., Lorber D., Steffen A., Willenz U., Bloch K., Vardi P., Taube R., de Vos P., Lewis E. C., Bornstein S. R., Rotem A. The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS One: 2013; 8 e70150
63. Ludwig B., Reichel A., Steffen A., Zimerman B., Schally A. V., Block N. L., Colton C. K., Ludwig S., Kersting S., Bonifacio E., Solimena M., Gendler Z., Rotem A., Barkai U., Bornstein S. R. Transplantation of human islets without immunosuppression. Proc Natl Acad Sci USA: 2013; 110 19054 19058.